DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

JP Morgan Downgrades BioNTech to Neutral, Announces $33 Price Target

JP Morgan analyst Cory Kasimov downgrades BioNTech (NASDAQ:BNTX) from Overweight to Neutral and announces $33 price target.

Benzinga · 03/18/2020 09:35

JP Morgan analyst Cory Kasimov downgrades BioNTech (NASDAQ:BNTX) from Overweight to Neutral and announces $33 price target.